Why Evolent Health, Inc.’s (EVH) Stock Is Up 16.18%
As of Friday, November 20, Evolent Health, Inc.’s EVH share price has surged by 16.18%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Tudor Pop
Tudor Pop
Tudor Pop
Rosalio Madrigal
| Share Statistics | EVH | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $441.1 | $248.6 | 38% |
|
| Shares Out (Mil) | 113.1 | 55.3 | 64% |
|
| Institutional Ownership | 97.9% | 81.3% | 76% |
|
| Float (Mil) | 110.9 | 45.0 | 62% |
|
| Beta | 1.02 | 1.19 | 60% |
|
| Avg Daily Volume (000s) | 2,275 | 377 | 83% |
|
| Price Change (52-week) |
10.2% | 54.6% | 64% |
|
| Growth | EVH | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 15.2% | 13.5% | 73% |
|
| Net Income (5yr) | (9.8%) | 5.4% | 29% |
|
| EPS (5yr) | (5.2%) | 15.5% | 25 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (62.6%) | (15.5%) | 4% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 10 | 10 | 9 | |
| Current EPS | $0.166 | $0.233 | $0.423 | |
| Month Ago EPS | $0.147 | $0.200 | $0.404 | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | $0.146 | $0.200 | $0.391 | |
| Year/Year Chg | (179.8%) | (104.6%) | (110.4%) | |
| Financials | EVH | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,343 | $211 | 62% |
|
| Net Income (TTM) (Mil) | ($508) | ($10) | 2% |
|
| EPS (TTM) | ($4.522) | ($0.800) | 8% |
|
| Operating Cash Flow (TTM) (Mil) | $65 | $10 | 48% |
|
| Net Cash Flow (TTM) (Mil) | $13 | $3 | 60% |
|
| Long-Term Debt (Q1) (Mil) | $972 | $12 | 66% |
|
| Enterprise Value (Q1) (Mil) | $1,343 | $190 | 45% |
|
| Valuation | EVH | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.18 | 1.05 | 36% |
|
| P/E | na | 39.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.4 | na |
|
| Ratios | EVH | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 15.0% | 61.3% | 14% |
|
| Net Margin | (21.7%) | (21.7%) | 16% |
|
| ROA | (23.0%) | (15.6%) | 19% |
|
| ROE | (83.6%) | (15.3%) | 10% |
|
| Liabilities to Assets | 81.0% | 32.1% | 76% |
|
| F-Score | 5 | 4 | 50% |
|
Evolent Health, Inc. did not pass any screens on 11/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors